During the past decade, The Arrhythmia Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Arrhythmia Institute" #1 collaborator was "Milton S. Hershey Medical Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Arrhythmia Institute" are "Heart Failure" (1 trials), "Implantable Defibrillator User" (1 trials), "Primary Prevention of Sudden Cardiac Arrest" (1 trials), "Secondary Prevention of Sudden Cardiac Arrest" (1 trials) and "Sudden Cardiac Death" (1 trials). Many other conditions were trialed in "The Arrhythmia Institute" in a lesser frequency.

Most popular intervention types in "The Arrhythmia Institute" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "COGNIS CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Arrhythmia Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Arrhythmia Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Arrhythmia Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Arrhythmia Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".